Protein degradation-focused Lycia Therapeutics launches with $50 million from Versant
Update: 2025-10-09
Description
�Lycia (LISS-ee-uh) Therapeutics has come out of stealth mode, revealing that it is working to develop a new generation of protein degraders, which are drugs that break down rather than inhibit misbehaving proteins.The biotech company is working with a 50 million dollar cash infusion from Versant ....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Columbia Peaks, Item Tile, Metadata, PNG, Spectrogram, VBR MP3
Comments
In Channel